RecruitingPhase 2NCT07459647
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Sponsor: MapLight Therapeutics
Little Rock, AR · Rogers, AR · +42 more sites
Phase 2 Schizophrenia clinical trials
13 recruiting Phase 2 schizophrenia studies in the US. What trial phases mean
Other phases
RecruitingPhase 2NCT07410507
A Study of Brenipatide in Adult Participants With Schizophrenia
Sponsor: Eli Lilly and Company
Little Rock, AR · Bellflower, CA · Garden Grove, CA · +29 more sites
RecruitingPhase 2NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Sponsor: MapLight Therapeutics
Phoenix, AZ · Scottsdale, AZ · Tucson, AZ · +34 more sites
RecruitingPhase 2NCT06540833
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Sponsor: Intra-Cellular Therapies, Inc.
Anaheim, CA · Los Alamitos, CA · Newport Beach, CA · +25 more sites
RecruitingPhase 2NCT07680946
Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Sponsor: TG Therapeutics, Inc.
Little Rock, AR · Richardson, TX
RecruitingPhase 2NCT07145918
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Sponsor: AbbVie
Little Rock, AR · Glendale, CA · Los Alamitos, CA · +4 more sites
RecruitingPhase 2NCT07467993
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Sponsor: Novartis Pharmaceuticals
Bentonville, AR · Pico Rivera, CA · Miami, FL · +4 more sites
RecruitingPhase 2NCT06376734
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
Sponsor: Brigham and Women's Hospital
Sunnyvale, CA · Boston, MA
RecruitingPhase 2NCT07191483
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Sponsor: Kynexis B.V.
Little Rock, AR · Cerritos, CA · Lemon Grove, CA · +12 more sites
RecruitingPhase 2NCT05778591
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
Sponsor: University of California, Los Angeles
Los Angeles, CA
RecruitingPhase 2NCT04226898
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Sponsor: Sheppard Pratt Health System
Batlimore, MD
RecruitingPhase 2NCT06502964
Study of ALTO-101 in Patients With Schizophrenia
Sponsor: Alto Neuroscience
Garden Grove, CA · Los Angeles, CA · Orange, CA · +11 more sites
Not yet recruitingPhase 2NCT07850102
Brain Imaging of DSP-2342
Sponsor: Johns Hopkins University
Baltimore, MD
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.